Entries by Mark Gowland

ADHEREX ANNOUNCES WARRANT EXCHANGE RESULTS AND NEW CAPITAL STRUCTURE

Research Triangle Park, NC, August 8, 2014 – – Adherex Technologies Inc. (TSX: AXH, OTCQB: ADHXF), today reported the final results of the Warrant exchange which concluded on July 29, 2014.  Approximately, 71% of all outstanding warrants originally issued by the Company on April 30, 2010 and 48% of all outstanding warrants issued on March 29, 2011 participated in the exchange. […]

ADHEREX TECHNOLOGIES INC. ANNOUNCES WARRANT EXCHANGE

RESEARCH TRIANGLE PARK, NC, June 30, 2014 – Adherex Technologies Inc. (TSX: AHX; OTC: ADHXF) (the “Company”) today announced it is offering holders of warrants originally issued by the Company on or about April 30, 2010 and March 29, 2011 the opportunity to exchange 180 warrants for one new warrant to purchase one share of […]

ADHEREX ANNOUNCES RESULTS FROM TWO SODIUM THIOSULFATE PHASE 3 STUDIES PRESENTED AT THE 50TH AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO) MEETING

  –COG STUDY ACCL0431 meets primary endpoint for prevention of cisplatin-induced hearing loss in children -SIOPEL 6 Data Monitoring Committee recommends continuation of study after safety review of 80 standard risk hepatoblastoma patients   Research Triangle Park, NC — June 2, 2014 – Adherex Technologies, Inc. (TSX: AHX, OTC: ADHXF) today announced the results on the […]

Adherex Announces Results of Annual and Special Meeting

Research Triangle Park, NC — (Marketwire) – May 30, 2014 – Adherex Technologies Inc. (TSX:AHX, OTC: ADHXF) today announced that the nominees listed in the management proxy circular dated April 28,2014 (the “Circular”) for the Annual and Special Meeting of Shareholders were elected as directors of the Company at the Annual and Special Meeting of […]

Adherex Responds to Trading Activity

Research Triangle Park, NC — (Marketwire) – May 27, 2014 – Adherex Technologies Inc. (TSX:AHX, OTC: ADHXF) is responding to a request from the Investment Industry Regulatory Organization of Canada on behalf of the Toronto Stock Exchange following recent trading activity. Ordinarily, the Company’s policy is not to comment on rumors or speculation.  Adherex is […]

Adherex Provides Corporate Update and Fiscal Year Ended December 31, 2013 Financial Results

RESEARCH TRIANGLE PARK, NORTH CAROLINA–(Marketwired – Mar 31, 2014) – Adherex Technologies Inc. (AHX.TO)(ADHXF), today reported its financial results and recent developments for the year ended December 31, 2013. All amounts are in US dollars unless otherwise specified. The two Phase 3 clinical trials studying Sodium Thiosulfate (STS) for prevention of hearing loss in children receiving […]

Adherex Announces Sodium Thiosulfate Clinical Study Update

RESEARCH TRIANGLE PARK, NORTH CAROLINA–(Marketwired – Feb 27, 2014) – Adherex Technologies, Inc. (AHX.TO)(ADHXF) today announced that the Children’s Oncology Group (COG), posted top line results on http://clinicaltrials.gov/ under Study ACCL0431, A Randomized Phase III Study of Sodium Thiosulfate for the Prevention of Cisplatin-Induced Ototoxicity in Children. No statistical analysis was published and a full analysis of all […]